Home>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>(R)-(+)-Etomoxir sodium salt

(R)-(+)-Etomoxir sodium salt Sale

(Synonyms: (R)-(+)-乙莫克舍钠盐,(R)-(+)-Etomoxir sodium salt) 目录号 : GC15104

(R)-(+)-Etomoxir sodium salt(Etomoxir) is a small molecule developed for metabolic and cardiovascular disease that exhibits nanomolar potency toward CPT-1a and CPT-1b upon enzymatic conversion to the active inhibitor etomoxiryl CoA (IC50 = 0.

(R)-(+)-Etomoxir sodium salt Chemical Structure

Cas No.:828934-41-4

规格 价格 库存 购买数量
10mM (in 1mL DMSO)
¥651.00
现货
10mg
¥956.00
现货
50mg
¥4,389.00
现货
500mg
¥26,334.00
现货
1g
¥41,790.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

产品文档

Quality Control & SDS

View current batch:

实验参考方法

Cell experiment [1]:

Cell lines

Human T cells

Preparation Method

Activated T cells (day 3) were treated with 50 µM (R)-(+)-Etomoxir sodium salt every other day throughout logarithmic expansion.

Reaction Conditions

50 µM Etomoxir; every other day in 10days

Applications

Etomoxir reduces CD28-costimulated T cell proliferation without affecting T cell effector differentiation.

Animal experiment [2]:

Animal models

Male BALB/c nude mice (3 weeks old)

Preparation Method

Mice with approximately 3 mm tumors(T24 cells)were assigned to two groups (n=5) randomly. Etomoxir (40 mg/kg) and vehicle were injected intraperitoneally every other day for 20 days.

Dosage form

40 mg/kg;i.p; every other day for 20 days

Applications

Etomoxir suppressed human bladder cancer (BCa) cell growth in vivo.

References:

[1]. O'Connor RS, Guo L, et,al. The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations. Sci Rep. 2018 Apr 19;8(1):6289. doi: 10.1038/s41598-018-24676-6. PMID: 29674640; PMCID: PMC5908836.
[2]. Cheng S, Wang G, et,al. Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer. Clin Sci (Lond). 2019 Aug 7;133(15):1745-1758. doi: 10.1042/CS20190587. PMID: 31358595.

产品描述

(R)-(+)-Etomoxir sodium salt(Etomoxir) is a small molecule developed for metabolic and cardiovascular disease that exhibits nanomolar potency toward CPT-1a and CPT-1b upon enzymatic conversion to the active inhibitor etomoxiryl CoA (IC50 = 0.01-0.70 µM) [1-3].

Etomoxir (50 µM ETO; every other day in 10days) reduces CD28-costimulated T cell proliferation without affecting T cell effector differentiation[4]. Low concentrations(3µM,24h) of etomoxir effectively inhibit CPT-1 but do not affect M(IL-4) polarization, High concentrations of Etomoxir (200 µM) inhibit M(IL-4) polarization independently of CPT-1 activity in BMDM cells[5]. Besides the effect of etomoxil on T cell differentiation and function was independent of Cpt1a expression [6].

Etomoxir (40 mg/kg;i.p; every other day for 20 days) suppressed human bladder cancer (BCa) cell growth in vivo[7]. Etomoxir (i.p; 1 mg/kg Etomoxir; twice every week) significantly inhibits the decrease of bone mineral density (BMD) and bone breaking strength in db/db and high fat (HF)-fed mice and suppresses the reduction of BMSCs-differentiated osteoblasts [8].

(R)-(+)-Etomoxir sodium salt(Etomoxir; ETO)是一种用于代谢和心血管疾病的小分子,经酶转化为活性抑制剂乙托莫西里尔辅酶a (IC50 约为0.01-0.70 µM)后,对CPT-1a和CPT-1b的抑制表现出纳摩尔效价[1-3]。

Etomoxir能减少CD28共刺激的T细胞增殖而不影响T细胞效应分化[4]。低浓度(3µM,24h) Etomoxir可有效抑制CPT-1,但不影响M(IL-4)极化,高浓度(200 µM) Etomoxir可抑制BMDM细胞中M(IL-4)极化,而不影响CPT-1活性[5]。Etomoxir对T细胞分化和功能的影响不依赖于Cpt1a的表达[6]。

Etomoxir (40 mg/kg;i.p; every other day for 20 days)体内抑制人膀胱癌(BCa)细胞生长[7]。Etomoxir(i.p; 1 mg/kg Etomoxir; twice every week)抑制db/db和高脂喂养小鼠骨密度(BMD)和骨折强度的下降,抑制BMSCs分化成骨细胞的减少[8]。

References:
[1]. O'Connor RS, Guo L, et,al.The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations. Sci Rep. 2018 Apr 19;8(1):6289. doi: 10.1038/s41598-018-24676-6. PMID: 29674640; PMCID: PMC5908836.
[2]. Divakaruni AS, Hsieh WY, et,al. Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis. Cell Metab. 2018 Sep 4;28(3):490-503.e7. doi: 10.1016/j.cmet.2018.06.001. Epub 2018 Jun 28. PMID: 30043752; PMCID: PMC6125190.
[3]. Ceccarelli SM, Chomienne O, et,al. Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research. J Med Chem. 2011 May 12;54(9):3109-52. doi: 10.1021/jm100809g. Epub 2011 Apr 19. PMID: 21504156.
[4]. O'Connor RS, Guo L, et,al. The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations. Sci Rep. 2018 Apr 19;8(1):6289. doi: 10.1038/s41598-018-24676-6. PMID: 29674640; PMCID: PMC5908836.
[5]. Divakaruni AS, Hsieh WY, et,al. Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis. Cell Metab. 2018 Sep 4;28(3):490-503.e7. doi: 10.1016/j.cmet.2018.06.001. Epub 2018 Jun 28. PMID: 30043752; PMCID: PMC6125190.
[6]. Raud B, Roy DG, et,al. Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation. Cell Metab. 2018 Sep 4;28(3):504-515.e7. doi: 10.1016/j.cmet.2018.06.002. Epub 2018 Jun 28. PMID: 30043753; PMCID: PMC6747686.
[7]. Cheng S, Wang G, et,al.Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer. Clin Sci (Lond). 2019 Aug 7;133(15):1745-1758. doi: 10.1042/CS20190587. PMID: 31358595.
[8]. Li J, He W, et,al.FFA-ROS-P53-mediated mitochondrial apoptosis contributes to reduction of osteoblastogenesis and bone mass in type 2 diabetes mellitus. Sci Rep. 2015 Jul 31;5:12724. doi: 10.1038/srep12724. PMID: 26226833; PMCID: PMC4521203.

Chemical Properties

Cas No. 828934-41-4 SDF
别名 (R)-(+)-乙莫克舍钠盐,(R)-(+)-Etomoxir sodium salt
化学名 sodium (R)-2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate
Canonical SMILES ClC1=CC=C(C=C1)OCCCCCC[C@@]2(C([O-])=O)OC2.[Na+]
分子式 C15H18ClNaO4 分子量 320.74
溶解度 ≥ 50mg/mL in DMSO,≥ 5mg/mL in H2O 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 3.1178 mL 15.589 mL 31.1779 mL
5 mM 0.6236 mL 3.1178 mL 6.2356 mL
10 mM 0.3118 mL 1.5589 mL 3.1178 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置